Healthy Skepticism Library item: 6991

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: news

Eli Lilly Awards $10 Million to International Diabetes
Philantropy News Digest 2006 Dec 6

Abstract:

Federation The International Diabetes Federation and Indianapolis-based Eli Lilly and Company have announced a long-term partnership to identify, test, and publish practical solutions to improve outcomes for people throughout the world living with diabetes.
During the World Diabetes Conference in Cape Town, South Africa, the partners unveiled a new joint program, Bringing Research in Diabetes to Global Environments and Systems (BRIDGES), funded by a seven-year, $10 million grant from Lilly.
BRIDGES will support translational research projects in diabetes and provide the opportunity to apply lessons learned from clinical research to people with diabetes. Researchers will be able to share insights and advice for improving their projects, leading to findings that can be applied in different settings.
A steering committee appointed by IDF will determine the amounts and types of grant awards, with the first grants to be announced before the end of 2007. Despite the development of new cutting-edge therapies, diabetes remains the world’s fourth-leading cause of death.
“While we remain deeply committed to scientific research and bringing breakthrough pharmaceutical products to the diabetes community, we know that success in diabetes won’t come through medical intervention alone,” said Jose Caro, M.D., vice president of Lilly and Company’s Global Diabetes Care Outcomes. “Innovative ideas are needed to help people with diabetes achieve better outcomes and live a more fulfilling life with diabetes in the long run.”